OncoCyte (OCX) Misses Q4 EPS by 193c

OncoCyte (NASDAQ: OCX) reported Q4 EPS of ($1.93). Revenue for the quarter came in at $1.49 million.

For earnings history and earnings-related data on OncoCyte (OCX) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Boeing wins $121 million Navy contract for P-8A upgrades
• A.O. Smith executive chairman to retire, CEO to assume chairman role